Excision BioTherapeutics

    Company Information

    Excision BioTherapeutics is based in Philadelphia, Pennsylvania, USA. The number of employees in Excision BioTherapeutics is unknown. Excision is developing crispr-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.

    Here is how Excision BioTherapeutics describes itself: "Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients."
      If you are the founder or part of the founding team, please tell the world your story


          Funding & investors

          Excision BioTherapeutics has received 6 rounds of venture funding. The total funding amount is around $70.8M.

            Similar Companies [beta]




              News

                Share:                    

                  Startup - Venture Capital - Innovation

                  Ventures Media is one of the largest startup and venture capital communities for startup and venture capital funding information and analysis.

                  Leave a Reply

                  Your email address will not be published. Required fields are marked *